Drug Shortage Report for ANANDRON
Report ID | 204346 |
Drug Identification Number | 02221861 |
Brand name | ANANDRON |
Common or Proper name | nilutamide |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | NILUTAMIDE |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | Box of 90 tablets |
ATC code | L02BB |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-09-18 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-11-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2023-11-18 | French | Compare |
v10 | 2023-11-18 | English | Compare |
v9 | 2023-11-18 | French | Compare |
v8 | 2023-11-18 | English | Compare |
v7 | 2023-10-05 | French | Compare |
v6 | 2023-10-05 | English | Compare |
v5 | 2023-10-04 | French | Compare |
v4 | 2023-10-04 | English | Compare |
v3 | 2023-09-19 | English | Compare |
v2 | 2023-09-14 | French | Compare |
v1 | 2023-09-14 | English | Compare |
Showing 1 to 11 of 11